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Introduction
Recent newspaper articles have heralded studies concluding
that smoking bans lead to dramatic decreases in the annual
1-3
incidence of acute myocardial infarction (AMI). Coupled with
studies concluding that bans never harm businesses and that
environmental tobacco smoke (ETS) significantly endangers
health of nonsmokers, studies claiming AMI reduction have
provided governments with additional evidence to support bans in
the name of public health.4,5
Some communities have expanded bans from workplaces to
include parks, beaches, and other open areas, based on this growing
body of evidence. This commentary argues that, as with distorted
claims regarding economic harm and ETS,6,7 recent studies
concluding that bans lower AMI incidence misrepresent public
health benefits of bans.
Studies Reporting DramaticAMI Reductions
Conclusions drawn in the recent Institute of Medicine (IOM)
8
report commissioned by the Centers for Disease Control and
Prevention (CDC) are often used as the rationale for expanding
smoking ban coverage. The IOM report examined 11 studies and
concluded that heart attack reduction caused by bans ranged from
6% to 47%, based on health outcomes measured by admission
records of local hospitals. CDC argues that effects are explained by
reduced ETS exposure among nonsmokers and reduced smoking,
with the former making the larger contribution.9 Studies that link
ETS exposure to increased rates of cardiovascular disease,
10-12
respiratory illness, and lung cancer are cited to rationalize claims
that bans dramatically improve health outcomes of nonsmokers.
The 11 studies examined effects of bans in the following
13-15
locations: three in overlapping regions of Italy; two in Pueblo,
Colorado (one with 18 months and one with 3 years of follow
9,16
17
up); and one each in Helena, Montana; Monroe County,
18
19
20
Indiana; Bowling Green, Ohio; New York State; Saskatoon,
21
22
Canada; and Scotland. Most studies compared health outcomes
in a single community with a smoking ban with those in nearby
communities without bans. Bans were argued to protect public
health when relative annual incidence of AMI fell in communities
with bans, compared to nearby communities lacking bans.

the U.S.23 The study concluded that bans do not significantly affect
health outcomes in the elderly, working-age, or pediatric populations.
Simulations from all possible small-scale studies using sub-samples
from the national data found that large short-term increases in AMI
incidence were as common as large short-term decreases following
bans. Thus, a random draw from the many locations adopting bans
would find that the number showing increases would equal the
number showing decreases inAMI incidence.
Common sense suggests that, given numerous bans enacted
worldwide, researchers can select jurisdictions that “prove” the
hypothesis that bans promote public health. This is clearly an
inappropriate research methodology because of the “file drawer” or
“publication” biases that arise when researchers selectively choose
data or studies to publish, cite, or ignore, based on their personal
judgments.6 “Cherry-picking” could explain how published studies
“find” that bans reduce the incidence of AMI despite zero change in
totalAMI incidence.
Most Studies Combine Smokers and Nonsmokers
Only two of 11 studies included in the IOM study—Monroe
County, Indiana, and Scotland—examine AMI incidence in
nonsmokers.18,22 This oversight apparently raised few concerns for
writers of the IOM study, who also admitted that none of their studies
had information on duration or pattern of ETS exposure, and thus also
had no information on whether ETS exposure changed as a result of
the ban. No information was collected on whether acute coronary
events were triggered by acute and sporadic or by chronic exposure to
ETS, or even whether bans induced some smokers to quit or reduce
smoking. The stridency of the IOM’s conclusions is puzzling in light
of the absence of information on previous ETS exposure and the
paucity of information on nonsmokers. The IOM study appears to
rationalize conclusions by the “precautionary principle”: resolve any
doubt in the direction of measures that claim to protect public health.

The evidence does not demonstrate that smoking bans
dramatically reduce AMI incidence. Major flaws include the
following five:

Studies Contain No Direct Evidence of ETS Risk
IOM admits that, because no direct evidence shows that brief
exposure to ETS can initiate heart attacks in nonsmokers, it relied on
indirect evidence associated with particulate matter from other
pollution sources to validate their assessment on health effects from
ETS. Selection bias is again apparent: The IOM report ignores
perhaps the most important study of the effects of ETS on
nonsmokers, the very large cohort study that followed, over a 40-year
period from 1959 to 1998, the health histories of more than 35,000
never-smoking Californians who were married to smokers. This
study found no causal link between ETS exposure and tobaccorelated mortality, and included spouses who smoked 80 or more
cigarettes per day.24 How can bans result in dramatic reductions in
AMI incidence in nonsmokers when so far it has not been possible to
show a causal link between ETS and poorer health in nonsmokers?

Small-Sample Bias
It is inappropriate to form strong conclusions based on a few
studies, especially when data are collected and analyzed on a
nonrandom basis. The only large-scale comprehensive study to date,
which is ignored in the IOM report, examined whether bans affect
hospitalization and mortality rates, based on thousands of cases across

Studies Ignore Other Health Factors
Only one study, which is ignored in the IOM report, perhaps
because it reported no effect from bans, has controlled for
confounding factors that may affect health outcomes, such as
smoking prevalence and improved prevention and treatment of
cardiovascular disease.23

Flawed Evidence
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Implausible Conclusions
Studies attribute AMI reductions of up to 47% to bans, even
though CDC itself claims only a 25%-30% increased risk of
25
developing heart disease from prolonged ETS exposure. Certainly
ETS exposure is unlikely to be beneficial, but CDC estimates are
not based on evidence from intermittent exposure associated with
public places.
Although authors of the IOM study expressed confidence in the
existence of an association between chronic ETS exposure and
AMI incidence, they also admitted there is no convincing evidence
of the magnitude of the association. It takes quite a leap of inference
to believe that smoking bans would offer such immediate and
dramatic health benefits of up to 47% fewer AMI admissions if
risks are truly associated with prolonged ETS exposure, and there is
no knowledge of the potential magnitude of effects on AMI
incidence from reduced exposure.
Moreover, most studies examined bans implemented for less
9
than 1 year, with the longest examining 3 years. Only two out of the
11 studies examined bans lasting 2 years or longer. For example, the
17
Helena, Montana, study, which found a 40% reduction in AMI,
based its conclusion on only 6 months of observation, during which
AMI admissions decreased by 16 (from 40 to 24)—a very small
sample size. During the baseline period, this hospital apparently
admitted, on average, fewer than seven patients a month withAMI.
Discussion
Publicly led research on public health effects of smoking bans
has overstated benefits by overreaching on conclusions, excluding
studies that contradict predetermined conclusions, and relying on
studies subject to biases outlined above. This pattern is lamentable
for a number of reasons. One is that efforts claiming to improve
public health appear to be driven more by social agendas than by
26,27
science.
The IOM released, and various media outlets
promulgated overstated claims on the public benefits of smoking
bans, apparently without even considering whether they met the
simplest tests of believability.
Another problem is that overstating health benefits from bans may
induce some individuals to alter behavior in ways that raise risk to
themselves and others. For instance, research shows that drunk driving
rises following bans in bars presumably because drinkers drive longer
distances in search of places where they may drink and smoke.28
Research also shows that, if bans lead smokers to smoke cigarettes
more intensely in anticipation of periods where they are subject to
29
bans, their health suffers. Moreover, claims that bans significantly
lower AMI incidence may lead some individuals to be less likely to
make lifestyle changes that could lower their personal risk.
Conclusions
Claims that smoking bans in public places have led to dramatic
reductions in AMI incidence are not supported by the evidence.
Scientifically invalid claims, though promulgated in the name of
protecting public health, have adverse consequences.
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